Key Points
-
Tissue kallikrein-related peptidases (KLKs) are a family of 15 secreted serine proteases expressed in various tissues and body fluids that are involved in multiple physiological processes
-
Several KLKs are abundantly expressed in the tissues of the female reproductive tract and are present at a high concentration in cervical-vaginal fluid (CVF)
-
pH is a key regulator of KLK activity and limited KLK activity is expected in CVF, owing to its low pH (≤4.5) in healthy women of reproductive age
-
Increased KLK activity is possible when the vaginal pH is elevated, owing to a disturbed vaginal microbiome, decreased oestrogen levels, or mixing of CVF with fluids of increased alkalinity
-
KLKs are presumably involved in proteolytic cascades related to antimicrobial processes, sperm transport, vaginal epithelial desquamation, and preterm premature rupture of membranes, through targeting of known and unknown KLK substrates
Abstract
Cervical-vaginal fluid (CVF) is a complex biological fluid that hydrates the mucosa of the lower female reproductive system. In-depth proteomic and biochemical studies on CVF have revealed that it contains large amounts of endogenous proteases and protease inhibitors, including an abundance of several members of the tissue kallikrein-related peptidase (KLK) family. Despite their ubiquitous presence in human tissues and fluids, KLK expression levels vary considerably, with maximum expression observed in reproduction-related tissues and fluids. The roles of KLKs in the lower female reproductive system are not fully understood. The activation of KLKs in CVF is dependent on pH and various modes of KLK regulation in the vagina exist. KLKs have been postulated to have roles in physiological functions related to antimicrobial processes, vaginal and cervical epithelial desquamation, sperm transport, and the processing of fetal membranes as observed in preterm premature rupture of membranes. Increased understanding of the functional roles of KLKs in the lower female reproductive system could lead to new diagnostic and therapeutic modalities for conditions such as vaginal infections and vaginal atrophy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Witkin, S. S. & Ledger, W. J. Complexities of the uniquely human vagina. Sci. Transl. Med. 4, 132fs11 (2012).
Whyte, J. J. et al. Maternal diet composition alters serum steroid and free fatty acid concentrations and vaginal pH in mice. J. Endocrinol. 192, 75–81 (2007).
Larsen, B., Markovetz, A. J. & Galask, R. P. The bacterial flora of the female rat genital tract. Proc. Soc. Exp. Biol. Med. 151, 571–574 (1976).
Jacques, M., Olson, M. E., Crichlow, A. M., Osborne, A. D. & Costerton, J. W. The normal microflora of the female rabbit's genital tract. Can. J. Vet. Res. 50, 272–274 (1986).
Spear, G. T. et al. Identification of rhesus macaque genital microbiota by 16S pyrosequencing shows similarities to human bacterial vaginosis: implications for use as an animal model for HIV vaginal infection. AIDS Res. Hum. Retroviruses 26, 193–200 (2010).
Linhares, I. M., Summers, P. R., Larsen, B., Giraldo, P. C. & Witkin, S. S. Contemporary perspectives on vaginal pH and lactobacilli. Am. J. Obstet. Gynecol. 204, 120.e1–120.e5 (2011).
Ravel, J. et al. Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. USA 108 (Suppl. 1), 4680–4687 (2011).
Doerflinger, S. Y., Throop, A. L. & Herbst-Kralovetz, M. M. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner. J. Infect. Dis. 209, 1989–1999 (2014).
Dixon, M. The effect of pH on the affinities of enzymes for substrates and inhibitors. Biochem. J. 55, 161–170 (1953).
Spear, G. T. et al. Effect of pH on cleavage of glycogen by vaginal enzymes. PLoS ONE 10, e0132646 (2015).
Yoon, H. et al. Activation profiles and regulatory cascades of the human kallikrein-related peptidases. J. Biol. Chem. 282, 31852–31864 (2007).
Shaw, J. L. & Diamandis, E. P. Distribution of 15 human kallikreins in tissues and biological fluids. Clin. Chem. 53, 1423–1432 (2007).
Uhlen, M. et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol. Cell. Proteomics 4, 1920–1932 (2005).
Uhlen, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419 (2015).
Fiedler, S. in Handbook of Experimental Pharmacology Vol. 25: Bradykinin, Kallidin and Kallikrein 103–161 (Springer Berlin Heidelberg, 1979).
Pathak, M., Wong, S. S., Dreveny, I. & Emsley, J. Structure of plasma and tissue kallikreins. Thromb. Haemost. 110, 423–433 (2013).
Yousef, G. M., Chang, A., Scorilas, A. & Diamandis, E. P. Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4. Biochem. Biophys. Res. Commun. 276, 125–133 (2000).
Yousef, G. M., Kopolovic, A. D., Elliott, M. B. & Diamandis, E. P. Genomic overview of serine proteases. Biochem. Biophys. Res. Commun. 305, 28–36 (2003).
Yousef, G. M. & Diamandis, E. P. The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev. 22, 184–204 (2001).
Harvey, T. J. et al. Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4. J. Biol. Chem. 275, 37397–37406 (2000).
Diamandis, E. P. et al. New nomenclature for the human tissue kallikrein gene family. Clin. Chem. 46, 1855–1858 (2000).
Gomis-Ruth, F. X. et al. The structure of human prokallikrein 6 reveals a novel activation mechanism for the kallikrein family. J. Biol. Chem. 277, 27273–27281 (2002).
Borgono, C. A. & Diamandis, E. P. The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer 4, 876–890 (2004).
Prassas, I., Eissa, A., Poda, G. & Diamandis, E. P. Unleashing the therapeutic potential of human kallikrein-related serine proteases. Nat. Rev. Drug Discov. 14, 183–202 (2015).
Smith, M. S., Lechago, J., Wines, D. R., MacDonald, R. J. & Hammer, R. E. Tissue-specific expression of kallikrein family transgenes in mice and rats. DNA Cell Biol. 11, 345–358 (1992).
Emami, N. & Diamandis, E. P. Human tissue kallikreins: a road under construction. Clin. Chim. Acta 381, 78–84 (2007).
Shaw, J. L., Petraki, C., Watson, C., Bocking, A. & Diamandis, E. P. Role of tissue kallikrein-related peptidases in cervical mucus remodeling and host defense. Biol. Chem. 389, 1513–1522 (2008).
Lizama, A. J. et al. Expression and bioregulation of the kallikrein-related peptidases family in the human neutrophil. Innate Immun. 21, 575–586 (2015).
Lasarte, S. et al. Sex hormones coordinate neutrophil immunity in the vagina by controlling chemokine gradients. J. Infect. Dis. 213, 476–484 (2015).
Fidel, P. L. Jr et al. An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. Infect. Immun. 72, 2939–2946 (2004).
Criss, A. K., Katz, B. Z. & Seifert, H. S. Resistance of Neisseria gonorrhoeae to non-oxidative killing by adherent human polymorphonuclear leucocytes. Cell. Microbiol. 11, 1074–1087 (2009).
Huggins, G. R. & Preti, G. Vaginal odors and secretions. Clin. Obstet. Gynecol. 24, 355–377 (1981).
Levin, R. J. & Wagner, G. Mechanisms for vaginal ion movements in women. J. Physiol. 284 (Suppl. 1), 172P–173P (1978).
Shaw, J. L., Smith, C. R. & Diamandis, E. P. Proteomic analysis of human cervico-vaginal fluid. J. Proteome Res. 6, 2859–2865 (2007).
Zegels, G., Van Raemdonck, G. A., Coen, E. P., Tjalma, W. A. & Van Ostade, X. W. Comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samples. Proteome Sci. 7, 17 (2009).
Goettig, P., Magdolen, V. & Brandstetter, H. Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs). Biochimie 92, 1546–1567 (2010).
Yu, Y., Prassas, I. & Diamandis, E. P. Putative kallikrein substrates and their (patho)biological functions. Biol. Chem. 395, 931–943 (2014).
Shaw, J. L. & Diamandis, E. P. Regulation of human tissue kallikrein-related peptidase expression by steroid hormones in 32 cell lines. Biol. Chem. 389, 1409–1419 (2008).
Naftolin, F. & Tolis, G. Neuroendocrine regulation of the menstrual cycle. Clin. Obstet. Gynecol. 21, 17–29 (1978).
Zarghami, N., Grass, L., Sauter, E. R. & Diamandis, E. P. Prostate-specific antigen in serum during the menstrual cycle. Clin. Chem. 43, 1862–1867 (1997).
Zarghami, N., Grass, L. & Diamandis, E. P. Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer. Br. J. Cancer 75, 579–588 (1997).
Yu, H., Diamandis, E. P., Zarghami, N. & Grass, L. Induction of prostate specific antigen production by steroids and tamoxifen in breast cancer cell lines. Breast Cancer Res. Treat. 32, 291–300 (1994).
Shaw, J. L. & Diamandis, E. P. A potential role for tissue kallikrein-related peptidases in human cervico-vaginal physiology. Biol. Chem. 389, 681–688 (2008).
Pampalakis, G., Diamandis, E. P. & Sotiropoulou, G. The epigenetic basis for the aberrant expression of kallikreins in human cancers. Biol. Chem. 387, 795–799 (2006).
Pampalakis, G. et al. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition. Cancer Res. 69, 3779–3787 (2009).
Olkhov-Mitsel, E. et al. Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer. Epigenetics 7, 1037–1045 (2012).
Jia, L. et al. Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells. Mol. Cell. Biol. 26, 7331–7341 (2006).
Pasic, M. D., Olkhov, E., Bapat, B. & Yousef, G. M. Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there. Biol. Chem. 393, 319–330 (2012).
Kang, G. H., Lee, S., Lee, H. J. & Hwang, K. S. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia. J. Pathol. 202, 233–240 (2004).
Chow, T. F. et al. Kallikreins as microRNA targets: an in silico and experimental-based analysis. Biol. Chem. 389, 731–738 (2008).
Amour, A. et al. General considerations for proteolytic cascades. Biochem. Soc. Trans. 32, 15–16 (2004).
Yoon, H., Blaber, S. I., Li, W., Scarisbrick, I. A. & Blaber, M. Activation profiles of human kallikrein-related peptidases by matrix metalloproteinases. Biol. Chem. 394, 137–147 (2013).
Yoon, H. et al. A completed KLK activome profile: investigation of activation profiles of KLK9, 10, and 15. Biol. Chem. 390, 373–377 (2009).
Bayes, A. et al. Human kallikrein 6 activity is regulated via an autoproteolytic mechanism of activation/inactivation. Biol. Chem. 385, 517–524 (2004).
Wagner, G. & Levin, R. J. Electrolytes in vaginal fluid during the menstrual cycle of coitally active and inactive women. J. Reprod. Fertil. 60, 17–27 (1980).
Chia, S. E., Ong, C. N., Chua, L. H., Ho, L. M. & Tay, S. K. Comparison of zinc concentrations in blood and seminal plasma and the various sperm parameters between fertile and infertile men. J. Androl. 21, 53–57 (2000).
Fischer, J. & Meyer-Hoffert, U. Regulation of kallikrein-related peptidases in the skin - from physiology to diseases to therapeutic options. Thromb. Haemost. 110, 442–449 (2013).
Brattsand, M., Stefansson, K., Lundh, C., Haasum, Y. & Egelrud, T. A proteolytic cascade of kallikreins in the stratum corneum. J. Invest. Dermatol. 124, 198–203 (2005).
Schechter, N. M. et al. Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI). Biol. Chem. 386, 1173–1184 (2005).
Deraison, C. et al. LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction. Mol. Biol. Cell 18, 3607–3619 (2007).
Lambers, H., Piessens, S., Bloem, A., Pronk, H. & Finkel, P. Natural skin surface pH is on average below 5, which is beneficial for its resident flora. Int. J. Cosmet. Sci. 28, 359–370 (2006).
Murta, E. F., Filho, A. C. & Barcelos, A. C. Relation between vaginal and endocervical pH in pre- and post-menopausal women. Arch. Gynecol. Obstet. 272, 211–213 (2005).
Amsel, R. et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 74, 14–22 (1983).
Garcia-Closas, M. et al. Epidemiologic determinants of vaginal pH. Am. J. Obstet. Gynecol. 180, 1060–1066 (1999).
Lang, W. R. Vaginal acidity and pH; a review. Obstet. Gynecol. Surv. 10, 546–560 (1955).
Owen, D. H. & Katz, D. F. A vaginal fluid simulant. Contraception 59, 91–95 (1999).
O'Hanlon, D. E., Moench, T. R. & Cone, R. A. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota. PLoS ONE 8, e80074 (2013).
Caillouette, J. C., Sharp, C. F. Jr, Zimmerman, G. J. & Roy, S. Vaginal pH as a marker for bacterial pathogens and menopausal status. Am. J. Obstet. Gynecol. 176, 1270–1275 (1997).
Milsom, I., Arvidsson, L., Ekelund, P., Molander, U. & Eriksson, O. Factors influencing vaginal cytology, pH and bacterial flora in elderly women. Acta Obstet. Gynecol. Scand. 72, 286–291 (1993).
Boskey, E. R., Cone, R. A., Whaley, K. J. & Moench, T. R. Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum. Reprod. 16, 1809–1813 (2001).
Boskey, E. R., Telsch, K. M., Whaley, K. J., Moench, T. R. & Cone, R. A. Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect. Immun. 67, 5170–5175 (1999).
Spitzbart, H. Vaginal wall glycogen and the formation of lactic acid. Z. Geburtshilfe Gynakol. 165, 297–300 (in German) (1966).
Gorodeski, G. I., Hopfer, U., Liu, C. C. & Margles, E. Estrogen acidifies vaginal pH by up-regulation of proton secretion via the apical membrane of vaginal-ectocervical epithelial cells. Endocrinology 146, 816–824 (2005).
Gorodeski, G. I. Effects of estrogen on proton secretion via the apical membrane in vaginal-ectocervical epithelial cells of postmenopausal women. Menopause 12, 679–684 (2005).
Daya, S. Follicular fluid pH changes following intraperitoneal exposure of Graafian follicles to carbon dioxide: a comparative study with follicles exposed to ultrasound. Hum. Reprod. 3, 727–730 (1988).
Leese, H. J. The formation and function of oviduct fluid. J. Reprod. Fertil. 82, 843–856 (1988).
Hantoushzadeh, S. et al. Elevated vaginal pH in the absence of current vaginal infection, still a challenging obstetrical problem. J. Matern. Fetal Neonatal Med. 27, 582–587 (2014).
Borges, S., Silva, J. & Teixeira, P. The role of lactobacilli and probiotics in maintaining vaginal health. Arch. Gynecol. Obstet. 289, 479–489 (2014).
Ma, B., Forney, L. J. & Ravel, J. Vaginal microbiome: rethinking health and disease. Annu. Rev. Microbiol. 66, 371–389 (2012).
Witkin, S. S. The vaginal microbiome, vaginal anti-microbial defence mechanisms and the clinical challenge of reducing infection-related preterm birth. BJOG 122, 213–218 (2015).
Leppaluoto, P. A. Bacterial vaginosis: what is physiological in vaginal bacteriology? An update and opinion. Acta Obstet. Gynecol. Scand. 90, 1302–1306 (2011).
Larsson, P. G. et al. Bacterial vaginosis. Transmission, role in genital tract infection and pregnancy outcome: an enigma. APMIS 113, 233–245 (2005).
Hemalatha, R., Ramalaxmi, B. A., Swetha, E., Balakrishna, N. & Mastromarino, P. Evaluation of vaginal pH for detection of bacterial vaginosis. Indian J. Med. Res. 138, 354–359 (2013).
Das, S. & Allan, S. Higher vaginal pH is associated with Neisseria gonorrhoeae and Chlamydia trachomatis infection in a predominantly white population. Sex. Transm. Dis. 33, 527–528 (2006).
Huppert, J. S., Bates, J. R., Weber, A. F., Quinn, N. & Gaydos, C. A. Abnormal vaginal pH and mycoplasma genitalium infection. J. Pediatr. Adolesc. Gynecol. 26, 36–39 (2013).
Das, S., Sabin, C. & Allan, S. Higher vaginal pH is associated with Chlamydia trachomatis infection in women: a prospective case-controlled study. Int. J. STD AIDS 16, 290–293 (2005).
Clarke, M. A. et al. A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection. BMC Infect. Dis. 12, 33 (2012).
Huppert, J. S., Huang, B., Chen, C., Dawood, H. Y. & Fichorova, R. N. Clinical evidence for the role of Trichomonas vaginalis in regulation of secretory leukocyte protease inhibitor in the female genital tract. J. Infect. Dis. 207, 1462–1470 (2013).
Yarbrough, V. L., Winkle, S. & Herbst-Kralovetz, M. M. Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications. Hum. Reprod. Update 21, 353–377 (2014).
Cole, A. M. Innate host defense of human vaginal and cervical mucosae. Curr. Top. Microbiol. Immunol. 306, 199–230 (2006).
Hickey, D. K., Patel, M. V., Fahey, J. V. & Wira, C. R. Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections. J. Reprod. Immunol. 88, 185–194 (2011).
Valore, E. V., Wiley, D. J. & Ganz, T. Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis. Infect. Immun. 74, 5693–5702 (2006).
Yamasaki, K. et al. Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J. 20, 2068–2080 (2006).
Ohlsson, K., Bjartell, A. & Lilja, H. Secretory leucocyte protease inhibitor in the male genital tract: PSA-induced proteolytic processing in human semen and tissue localization. J. Androl. 16, 64–74 (1995).
Eissa, A., Amodeo, V., Smith, C. R. & Diamandis, E. P. Kallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade. J. Biol. Chem. 286, 687–706 (2011).
De Vuyst, H., Clifford, G. M., Nascimento, M. C., Madeleine, M. M. & Franceschi, S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int. J. Cancer 124, 1626–1636 (2009).
Smith, J. S. et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int. J. Cancer 121, 621–632 (2007).
Cerqueira, C., Samperio Ventayol, P., Vogeley, C. & Schelhaas, M. Kallikrein-8 proteolytically processes human papillomaviruses in the extracellular space to facilitate entry into host cells. J. Virol. 89, 7038–7052 (2015).
Hamilton, B. S. & Whittaker, G. R. Cleavage activation of human-adapted influenza virus subtypes by kallikrein-related peptidases 5 and 12. J. Biol. Chem. 288, 17399–17407 (2013).
Herold, B. C., Mesquita, P. M., Madan, R. P. & Keller, M. J. Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections. Am. J. Reprod. Immunol. 65, 325–333 (2011).
Li, Y. et al. Activation of protease-activated receptor-2 disrupts vaginal epithelial barrier function. Cell Biol. Int. 38, 1247–1251 (2014).
Hollenberg, M. D. et al. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer. Biol. Chem. 389, 643–651 (2008).
Blaskewicz, C. D., Pudney, J. & Anderson, D. J. Structure and function of intercellular junctions in human cervical and vaginal mucosal epithelia. Biol. Reprod. 85, 97–104 (2011).
Anderson, D. J., Marathe, J. & Pudney, J. The structure of the human vaginal stratum corneum and its role in immune defense. Am. J. Reprod. Immunol. 71, 618–623 (2014).
Averette, H. E., Weinstein, G. D. & Frost, P. Autoradiographic analysis of cell proliferation kinetics in human genital tissues. I. Normal cervix and vagina. Am. J. Obstet. Gynecol. 108, 8–17 (1970).
Caubet, C. et al. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J. Invest. Dermatol. 122, 1235–1244 (2004).
Borgono, C. A. et al. A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. J. Biol. Chem. 282, 3640–3652 (2007).
Ishida-Yamamoto, A. et al. LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum. J. Invest. Dermatol. 124, 360–366 (2005).
Ishida-Yamamoto, A. & Igawa, S. The biology and regulation of corneodesmosomes. Cell Tissue Res. 360, 477–482 (2015).
Ohler, A., Debela, M., Wagner, S., Magdolen, V. & Becker-Pauly, C. Analyzing the protease web in skin: meprin metalloproteases are activated specifically by KLK4, 5 and 8 vice versa leading to processing of proKLK7 thereby triggering its activation. Biol. Chem. 391, 455–460 (2010).
Sales, K. U. et al. Matriptase initiates activation of epidermal pro-kallikrein and disease onset in a mouse model of Netherton syndrome. Nat. Genet. 42, 676–683 (2010).
Miyai, M. et al. Keratinocyte-specific mesotrypsin contributes to the desquamation process via kallikrein activation and LEKTI degradation. J. Invest. Dermatol. 134, 1665–1674 (2014).
Rahn, D. D. et al. Vaginal estrogen for genitourinary syndrome of menopause: a systematic review. Obstet. Gynecol. 124, 1147–1156 (2014).
Huang, A. J. et al. Vaginal symptoms in postmenopausal women: self-reported severity, natural history, and risk factors. Menopause 17, 121–126 (2010).
Portman, D. J. & Gass, M. L. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Menopause 21, 1063–1068 (2014).
Palma, F., Volpe, A., Villa, P. & Cagnacci, A. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: the AGATA study. Maturitas 83, 40–44 (2015).
van der Laak, J. A. et al. Development and validation of a computerized cytomorphometric method to assess the maturation of vaginal epithelial cells. Cytometry 35, 196–202 (1999).
Zhou, J. et al. The semen pH affects sperm motility and capacitation. PLoS ONE 10, e0132974 (2015).
Tocci, A. & Lucchini, C. WHO reference values for human semen. Hum. Reprod. Update 16, 559 (2010).
Harraway, C., Berger, N. G. & Dubin, N. H. Semen pH in patients with normal versus abnormal sperm characteristics. Am. J. Obstet. Gynecol. 182, 1045–1047 (2000).
Fox, C. A., Meldrum, S. J. & Watson, B. W. Continuous measurement by radio-telemetry of vaginal pH during human coitus. J. Reprod. Fertil. 33, 69–75 (1973).
Sobrero, A. J. & Macleod, J. The immediate postcoital test. Fertil. Steril. 13, 184–189 (1962).
Lilja, H. & Lundwall, A. Molecular cloning of epididymal and seminal vesicular transcripts encoding a semenogelin-related protein. Proc. Natl. Acad. Sci. USA 89, 4559–4563 (1992).
Marques, P. I. et al. Birth-and-death of KLK3 and KLK2 in primates: evolution driven by reproductive biology. Genome Biol. Evol. 4, 1331–1338 (2012).
Suarez, S. S. & Pacey, A. A. Sperm transport in the female reproductive tract. Hum. Reprod. Update 12, 23–37 (2006).
Gipson, I. K. et al. MUC4 and MUC5B transcripts are the prevalent mucin messenger ribonucleic acids of the human endocervix. Biol. Reprod. 60, 58–64 (1999).
Caughey, A. B., Robinson, J. N. & Norwitz, E. R. Contemporary diagnosis and management of preterm premature rupture of membranes. Rev. Obstet. Gynecol. 1, 11–22 (2008).
Goldenberg, R. L., Culhane, J. F., Iams, J. D. & Romero, R. Epidemiology and causes of preterm birth. Lancet 371, 75–84 (2008).
Perrini, M. et al. Mechanical and microstructural investigation of the cyclic behavior of human amnion. J. Biomech. Eng. 137, 061010 (2015).
Di Renzo, G. C. et al. Guidelines for the management of spontaneous preterm labor: identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes, and preventive tools for preterm birth. J. Matern. Fetal Neonatal Med. 24, 659–667 (2011).
Vadillo-Ortega, F. & Estrada-Gutierrez, G. Role of matrix metalloproteinases in preterm labour. BJOG 112, 19–22 (2005).
Weiss, A., Goldman, S. & Shalev, E. The matrix metalloproteinases (MMPS) in the decidua and fetal membranes. Front. Biosci. 12, 649–659 (2007).
Borgono, C. A. et al. Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14. J. Biol. Chem. 282, 2405–2422 (2007).
Michael, I. P. et al. Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression. J. Biol. Chem. 280, 14628–14635 (2005).
Magklara, A. et al. Characterization of the enzymatic activity of human kallikrein 6: autoactivation, substrate specificity, and regulation by inhibitors. Biochem. Biophys. Res. Commun. 307, 948–955 (2003).
Kapadia, C., Ghosh, M. C., Grass, L. & Diamandis, E. P. Human kallikrein 13 involvement in extracellular matrix degradation. Biochem. Biophys. Res. Commun. 323, 1084–1090 (2004).
Rajapakse, S. & Takahashi, T. Expression and enzymatic characterization of recombinant human kallikrein 14. Zoolog. Sci. 24, 774–780 (2007).
Ghosh, M. C., Grass, L., Soosaipillai, A., Sotiropoulou, G. & Diamandis, E. P. Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells. Tumour Biol. 25, 193–199 (2004).
Ramani, V. C. & Haun, R. S. The extracellular matrix protein fibronectin is a substrate for kallikrein 7. Biochem. Biophys. Res. Commun. 369, 1169–1173 (2008).
Park, J. S., Park, C. W., Lockwood, C. J. & Norwitz, E. R. Role of cytokines in preterm labor and birth. Minerva Ginecol. 57, 349–366 (2005).
Author information
Authors and Affiliations
Contributions
C.M.J.M., S.K.V., K.O., and I.P. researched data for and wrote the article. All authors made substantial contributions to dicussions of content and reviewed and edited the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Muytjens, C., Vasiliou, S., Oikonomopoulou, K. et al. Putative functions of tissue kallikrein-related peptidases in vaginal fluid. Nat Rev Urol 13, 596–607 (2016). https://doi.org/10.1038/nrurol.2016.161
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2016.161
This article is cited by
-
Remodelling of the tumour microenvironment by the kallikrein-related peptidases
Nature Reviews Cancer (2022)
-
Simulating nature in sperm selection for assisted reproduction
Nature Reviews Urology (2022)
-
mTORC1 signaling pathway integrates estrogen and growth factor to coordinate vaginal epithelial cells proliferation and differentiation
Cell Death & Disease (2022)
-
Quantitative proteomic profiling of Cervicovaginal fluid from pregnant women with term and preterm birth
Proteome Science (2021)
-
Proteomics and functional study reveal kallikrein-6 enhances communicating hydrocephalus
Clinical Proteomics (2021)